Clinical Trial Update: Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

View source ↗

Summary

An observational study of ALNA (tamsulosin) in benign prostatic hyperplasia has completed. The snippet provides the completion status but no study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• ALNA (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED